Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFLT
1151
DELISTED
Confluent
CFLT
| $40M | 0.01% |
1,719,652
+401,758
| +30% | +$10.8M |
|
1152
CALL
Fortinet
FTNT
$121B
| $39.9M | 0.01% |
706,000
-401,500
| -36% | -$23.8M |
|
1153
PUT
Rockwell Automation
ROK
$50.1B
| $39.9M | 0.01% |
200,300
+154,500
| +337% | +$34.9M |
|
1154
PUT
General Mills
GIS
$20.8B
| $39.9M | 0.01% |
528,700
+140,700
| +36% | +$9.86M |
|
1155
Liberty Global Class C
LBTYK
$3.46B
| $39.9M | 0.01% |
1,805,447
+93,830
| +5% | +$2.29M |
|
1156
PUT
Wheaton Precious Metals
WPM
$59.9B
| $39.9M | 0.01% |
1,106,500
-316,400
| -22% | -$13.7M |
|
1157
PUT
Kimberly-Clark
KMB
$36.8B
| $39.8M | 0.01% |
294,400
+27,400
| +10% | +$3.61M |
|
1158
CALL
Scotiabank
BNS
$110B
| $39.7M | 0.01% |
670,100
+522,400
| +354% | +$33.9M |
|
1159
Qualys
QLYS
$6.47B
| $39.7M | 0.01% |
314,444
+265,008
| +536% | +$34.7M |
|
1160
Apple Hospitality REIT
APLE
$3.71B
| $39.6M | 0.01% |
2,697,680
+2,552,211
| +1,754% | +$42.2M |
|
|
WWE
1161
DELISTED
World Wrestling Entertainment
WWE
| $39.4M | 0.01% |
631,077
+48,454
| +8% | +$2.99M |
|
1162
PUT
Eaton
ETN
$176B
| $39.4M | 0.01% |
312,400
+276,100
| +761% | +$38.6M |
|
1163
CALL
Bank of Montreal
BMO
$129B
| $39.3M | 0.01% |
408,600
+121,000
| +42% | +$12.9M |
|
1164
CALL
Teva Pharmaceuticals
TEVA
$42.6B
| $39.2M | 0.01% |
5,214,600
+3,372,600
| +183% | +$29.4M |
|
1165
CALL
Ecolab
ECL
$78.1B
| $39.2M | 0.01% |
254,900
+165,300
| +184% | +$27.4M |
|
|
HES
1166
CALL
DELISTED
Hess
HES
| $39.1M | 0.01% |
368,900
+89,900
| +32% | +$10.2M |
|
1167
CALL
Petrobras
PBR
$115B
| $39M | 0.01% |
3,339,400
-1,366,400
| -29% | -$18.9M |
|
1168
Cinemark Holdings
CNK
$4.37B
| $38.9M | 0.01% |
2,589,395
+39,226
| +2% | +$621K |
|
1169
PUT
Boston Scientific
BSX
$74.9B
| $38.8M | 0.01% |
1,041,000
+291,300
| +39% | +$11.9M |
|
|
1170
General Mills
GIS
$20.8B
| $38.8M | 0.01% |
513,803
-79,710
| -13% | -$5.58M |
|
1171
PUT
MSCI
MSCI
$41.8B
| $38.7M | 0.01% |
94,000
+28,700
| +44% | +$12.5M |
|
1172
CALL
LyondellBasell Industries
LYB
$20.2B
| $38.7M | 0.01% |
442,000
-118,500
| -21% | -$12.3M |
|
1173
Entegris
ENTG
$25B
| $38.6M | 0.01% |
419,486
+366,615
| +693% | +$39.7M |
|
1174
CALL
Diageo
DEO
$52.8B
| $38.6M | 0.01% |
221,900
+151,900
| +217% | +$28.9M |
|
1175
CALL
Burlington
BURL
$22.4B
| $38.6M | 0.01% |
283,500
+181,800
| +179% | +$32.9M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.